Veeva Systems (NYSE:VEEV – Get Free Report) issued its quarterly earnings data on Wednesday. The technology company reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12, FiscalAI reports. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The business had revenue of $835.95 million for the quarter, compared to analysts’ expectations of $810.95 million. During the same period in the prior year, the firm earned $1.74 EPS. The company’s revenue for the quarter was up 16.0% on a year-over-year basis. Veeva Systems updated its FY 2027 guidance to 8.850- EPS and its Q1 2027 guidance to 2.130-2.14 EPS.
Here are the key takeaways from Veeva Systems’ conference call:
- Veeva closed FY26 ahead of guidance with $836M in Q4 revenue and $3.195B for the year (non‑GAAP operating income of $1.434B), and said it has surpassed its $3B revenue run‑rate.
- Vault CRM momentum accelerated — Veeva is close to 140 customers live, expects roughly 14 of 20 top‑20 pharma migrations to Veeva, and sees CRM as a stable business contributing to long‑term revenue and cross‑sell opportunities.
- Veeva is positioning itself to deliver integrated AI “agents” (early use cases in commercial content and safety) and expects R&D agents to roll out this year, but management says AI is an important long‑term opportunity with limited immediate financial contribution.
- Crossix, which drove much of FY26 outperformance, will face tougher year‑over‑year comparisons in FY27 even though the business remains healthy and has a long runway for growth.
- Professional services and business consulting outperformed and remain profitable — services demand (including CRM migrations and study‑by‑study R&D work via CRO channels) is factored into FY27 guidance and expected to support revenue.
Veeva Systems Stock Performance
Shares of VEEV stock opened at $188.09 on Thursday. The stock has a 50 day moving average price of $204.58 and a 200 day moving average price of $248.39. Veeva Systems has a 52-week low of $168.13 and a 52-week high of $310.50. The firm has a market capitalization of $30.92 billion, a P/E ratio of 36.59, a P/E/G ratio of 1.28 and a beta of 1.09.
Insiders Place Their Bets
Hedge Funds Weigh In On Veeva Systems
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Invesco Ltd. increased its stake in shares of Veeva Systems by 12.5% during the fourth quarter. Invesco Ltd. now owns 323,302 shares of the technology company’s stock valued at $72,171,000 after buying an additional 35,832 shares during the period. Corient Private Wealth LLC grew its holdings in Veeva Systems by 33.4% during the 4th quarter. Corient Private Wealth LLC now owns 196,746 shares of the technology company’s stock worth $43,920,000 after acquiring an additional 49,279 shares in the last quarter. EP Wealth Advisors LLC purchased a new position in Veeva Systems during the 4th quarter valued at about $942,000. Coastal Bridge Advisors LLC increased its position in Veeva Systems by 47.3% during the 4th quarter. Coastal Bridge Advisors LLC now owns 1,022 shares of the technology company’s stock valued at $228,000 after purchasing an additional 328 shares during the period. Finally, Cim LLC raised its holdings in shares of Veeva Systems by 2.6% in the 4th quarter. Cim LLC now owns 5,712 shares of the technology company’s stock valued at $1,275,000 after purchasing an additional 146 shares in the last quarter. Institutional investors own 88.20% of the company’s stock.
Key Headlines Impacting Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Q4 beat and raised guidance — Veeva reported $836M in Q4 revenue (up ~16% YoY) and $2.06 non‑GAAP EPS, both above consensus; management issued FY‑27 EPS and revenue targets well above Street expectations, and Q1 guidance also topped forecasts, underpinning the rally. Veeva Announces Fourth Quarter and Fiscal Year 2026 Results
- Positive Sentiment: Strong guidance detail — Company gave FY‑27 EPS guidance of ~8.85 (above consensus ~7.59) and Q1 EPS of 2.13–2.14 (well above consensus), plus revenue guidance ahead of estimates, improving forward visibility for investors. Veeva Announces Fourth Quarter and Fiscal Year 2026 Results
- Positive Sentiment: Vault CRM adoption & AI momentum — Veeva said more than 125 customers are live on Vault CRM and signals CRM could be ~10% of revenue by 2030 as its agentic CRM and Veeva AI rollout accelerate, supporting a multi-year growth runway and TAM expansion. More Than 125 Customers Worldwide Live on Vault CRM
- Positive Sentiment: Analyst/media support on durability vs. AI fears — Several outlets and analysts flagged Veeva’s vertical focus and product positioning (Vault CRM + AI) as reasons it can withstand broader software/AI disruption concerns, helping sentiment. Veeva Systems Stock Rallies After Earnings
- Neutral Sentiment: Investor materials available — Full earnings release, presentation and call transcript were posted (useful for modeling and management commentary on CRM adoption and margins). These provide detail but no new surprise beyond the beat/guidance. Q4 Earnings Call Transcript
- Negative Sentiment: Analyst cuts and mixed reactions — Some analysts trimmed forecasts after the print (notably highlighted by coverage that some firms reduced estimates despite the beat), which could limit upside and add volatility as investors re‑work models. These Analysts Cut Their Forecasts On Veeva Systems Following Q4 Results
- Negative Sentiment: Competition and past management disclosures — Pre‑earnings coverage highlighted competitive pressure in CRM and a prior management disclosure that led to short‑term weakness; these competitive dynamics remain a watch item for longer‑term margin and share gains. Veeva Systems (VEEV) Retreated Following Management’s Competitive Losses Disclosure
Analyst Ratings Changes
VEEV has been the topic of a number of research reports. Truist Financial upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating in a report on Thursday, January 8th. Wells Fargo & Company dropped their price target on Veeva Systems from $341.00 to $333.00 and set an “overweight” rating for the company in a research report on Tuesday, November 25th. BTIG Research restated a “buy” rating and set a $340.00 price objective on shares of Veeva Systems in a research report on Friday, November 21st. Weiss Ratings lowered Veeva Systems from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. Finally, JPMorgan Chase & Co. dropped their target price on Veeva Systems from $330.00 to $296.00 and set an “overweight” rating for the company in a report on Friday, February 20th. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $287.67.
Get Our Latest Stock Analysis on VEEV
Veeva Systems announced that its Board of Directors has initiated a share buyback program on Monday, January 5th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the technology company to repurchase up to 5.5% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board believes its shares are undervalued.
Veeva Systems Company Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Further Reading
- Five stocks we like better than Veeva Systems
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
